Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Schmidt

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|March 29, 2016
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08Felicitas Hitz, Emanuele Zucca, Thomas Pabst, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2023
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT studyAngelika Hammerer-Lercher, Henning Nilius, Jan-Dirk Studt, et al.
Frontiers in Medicine|August 11, 2023
Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clonesAlicia Rovó, Mathilde Gavillet, Beatrice Drexler, et al.
Journal of Thrombosis and Haemostasis : JTH|November 13, 2024
The dynamic range of immunoassays for heparin-induced thrombocytopeniaHenning Nilius, Samra Naas, Jan-Dirk Studt, et al.
Swiss Medical Weekly|October 23, 2025
Updated recommendations for diagnosis and treatment of multiple myeloma in SwitzerlandMartina Bertschinger, Holger W Auner, Veronika Ballova, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2017
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II StudyPanagiotis Samaras, Markus F Rütti, Burkhardt Seifert, et al.
JAMA Network Open|March 26, 2024
Accuracy of Diagnosing Heparin-Induced ThrombocytopeniaEmil List Larsen, Henning Nilius, Jan-Dirk Studt, et al.
Hemasphere|September 5, 2020
Clonal Hematopoiesis in Hospitalized Elderly Patients With COVID-19Erik Hameister, Sebastian M Stolz, Yvonne Fuhrer, et al.
Blood Advances|April 8, 2024
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopeniaHenning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, et al.
Eclinicalmedicine|December 2, 2022
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational studyHenning Nilius, Adam Cuker, Sigve Haug, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|March 29, 2016
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08Felicitas Hitz, Emanuele Zucca, Thomas Pabst, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2023
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT studyAngelika Hammerer-Lercher, Henning Nilius, Jan-Dirk Studt, et al.
Frontiers in Medicine|August 11, 2023
Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clonesAlicia Rovó, Mathilde Gavillet, Beatrice Drexler, et al.
Journal of Thrombosis and Haemostasis : JTH|November 13, 2024
The dynamic range of immunoassays for heparin-induced thrombocytopeniaHenning Nilius, Samra Naas, Jan-Dirk Studt, et al.
Swiss Medical Weekly|October 23, 2025
Updated recommendations for diagnosis and treatment of multiple myeloma in SwitzerlandMartina Bertschinger, Holger W Auner, Veronika Ballova, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2017
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II StudyPanagiotis Samaras, Markus F Rütti, Burkhardt Seifert, et al.
JAMA Network Open|March 26, 2024
Accuracy of Diagnosing Heparin-Induced ThrombocytopeniaEmil List Larsen, Henning Nilius, Jan-Dirk Studt, et al.
Hemasphere|September 5, 2020
Clonal Hematopoiesis in Hospitalized Elderly Patients With COVID-19Erik Hameister, Sebastian M Stolz, Yvonne Fuhrer, et al.
Blood Advances|April 8, 2024
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopeniaHenning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, et al.
Eclinicalmedicine|December 2, 2022
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational studyHenning Nilius, Adam Cuker, Sigve Haug, et al.
Pageof 5